Type-1 diabetes (T1D) is caused by autoreactive T cells that selectively destroy insulin-secreting b cells in the pancreas. Loss of immunological tolerance to b cells causes T1D, but the underlying mechanisms are poorly understood, preventing the development of a cure for T1D. A major component of peripheral tolerance to prevent T1D is the regulation of circulating autoreactive T cells in lymph nodes (LNs) by interactions with tolerogenic Ag- presenting cells (APCs) and regulatory T cells, both of which appear to be defective in T1D. Fibroblastic reticular cells (FRCs) form the LN reticula that guide migration and interactions of T cells and APCs. FRCs are also responsible for remodeling the LN and allowing its expansion during inflammation. Relevant to autoimmune diseases, FRCs are non-professional APCs that can induce antigen-specific tolerance by expressing and presenting antigens to specific T cells without co-stimulatory signals, leading to T cell engagement (stimulation and proliferation) followed by deletion. Most studies have been done using transgenic mice for overexpression of artificial (not disease relevant) antigens in FRCs; thus, the role of FRCs in maintaining peripheral tolerance to disease-relevant self-antigens is poorly understood. We found that in T1D, relative frequency, antigen expression levels and reticular organization of LN FRCs are affected. One goal of this proposal is to use innovative tissue-engineered FRC reticula that recapitulate FRC reticular organization in the LN paracortex and T1D known self-antigen expression to study how FRC reticular properties (aim 1.1) and antigens expression levels (aim 2.1) affect T cell engagement in vitro through co-culture studies. While professional APCs can switch to immunogenic phenotypes and promote T1D, non-professional APCs like FRCs are less likely to do so. We showed that promoting formation of FRC reticula expressing T1D antigens is sufficient to induce tolerance and prevent T1D in non-obese diabetic (NOD) mice. Thus, a second goal of this proposal is to test in NOD mice whether we can delete autoreactive T cells from the systemic circulation to ameliorate T1D by (i) attracting them to implanted engineered reticula and by (ii) promoting tolerogenic T cell engagement by modulating FRC reticular properties (aim 1.2) and/or FRC antigen-expression levels (aim 2.2).

Public Health Relevance

Defects in the regulation of immune tolerance can lead to autoimmune diseases, wherein uncontrolled reactivity to self-antigens leads to tissue damage, loss of function and diseases affecting multiple organs. Autoimmune diseases, such as Type-1 diabetes, cause a major burden to our society, but novel approaches that safely and specifically regulate the responsible immune cells to prevent and treat autoimmune diseases are lacking. This work will improve our understanding of lymph nodes as sites of immune tolerance induction and will guide the development of new therapies for autoimmune diseases that involve overexpression of relevant self-antigens in stromal cells and/or increase of stromal cell numbers for tolerance induction.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
High Priority, Short Term Project Award (R56)
Project #
Application #
Study Section
Biomaterials and Biointerfaces Study Section (BMBI)
Program Officer
Rice, Jeffrey S
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Miami School of Medicine
Schools of Medicine
Coral Gables
United States
Zip Code